Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Raises $34M in Private Financing Round

NEW YORK, Nov. 12 – Fluidigm of South San Francisco, Calif., said Monday it had raised $34 million in a round of private financing and has secured commitments for an additional $4 million.

The maker of microfluidics technologies for use on biochips said that it would use the money it raised in the series C financing round to further develop and market its microfluidic pump and valve technology.

Fluidigm has developed a flexible rubber chip with built-in microfluidics circuits. Pumps and valves move small quantities of fluid through channels that are smaller in diameter than a human hair.

Lehman Brothers led the round, while Euclid SR, US Bancorp Piper Jaffray, GE Equity, Versant Ventures, and InterWest Partners, also participated in the round. Versant and InterWest previously invested in the company.

Fluidigm, which has raised a total of $50 milllion in private funds to date, currently employs 70 people and has offices in California and Colorado.

Revenues from biochips are expected to total $1.2 billion in 2004, Fluidigm said citing a UBS Warburg report.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.